Medical information Clinical review pending

Genetic Testing

Kit Gene Piebaldism Genetic Test

Genetic test to identify mutations in the KIT gene associated with Piebaldism, a condition affecting skin and hair pigmentation. Helps in diagnosis and family planning.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: Blood sample (EDTA tube), Extracted DNA, or One drop of blood on FTA Card.
Results: Approximately 3 to 4 weeks. Confirm with the laboratory before booking.
Preparation: No special preparation is required for this test. Please confirm specific requirements with the laboratory before sample collection.

Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Kit Gene Piebaldism Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Individuals presenting with symptoms suggestive of Piebaldism (e.g., congenital white patches of skin and hair).
✓Family history of Piebaldism or similar skin pigmentation disorders.
✓Genetic counseling for individuals or families affected by Piebaldism.
✓Prenatal diagnosis or carrier screening in families with a known history of KIT gene mutations causing Piebaldism.

In plain language

What this test helps you understand

This test helps identify specific genetic mutations in the KIT gene responsible for Piebaldism. It aids in confirming a diagnosis, understanding the genetic basis of the condition within a family, and assessing the risk of passing the condition to offspring. Results can guide genetic counseling and inform management strategies.

The KIT Gene Piebaldism NGS Genetic DNA Test is a specialized genetic analysis designed to detect mutations within the KIT gene. This gene plays a crucial role in the development of melanocytes, the cells responsible for skin and hair pigmentation. Piebaldism is a rare genetic condition characterized by the absence of melanocytes in specific areas, leading to patches of white skin and hair, typically present from birth. Understanding the genetic basis of Piebaldism can provide valuable information for affected individuals and their families. This test utilizes Next Generation Sequencing (NGS) technology for accurate detection of relevant mutations in the KIT gene. Early diagnosis and genetic counseling can help individuals understand the condition, manage potential associated health concerns, and make informed decisions about family planning.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationNo special preparation is required for this test. Please confirm specific requirements with the laboratory before sample collection.

SampleBlood sample (EDTA tube), Extracted DNA, or One drop of blood on FTA Card.

MethodologyNext Generation Sequencing (NGS) targeting the KIT gene.

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

This test primarily analyzes the KIT gene for mutations associated with Piebaldism. It may not detect all possible mutations or other genetic conditions that could cause similar symptoms. A negative result does not completely rule out Piebaldism if clinical suspicion is high. Interpretation of results should be done in conjunction with clinical findings and genetic counseling.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

Piebaldism is a rare genetic condition characterized by the absence of melanocytes (pigment-producing cells) in certain areas of the skin and hair, resulting in white patches, usually present from birth.

This test helps confirm a diagnosis of Piebaldism by identifying mutations in the KIT gene. It can also provide information for genetic counseling and family planning.

A blood sample, extracted DNA, or a single drop of blood on an FTA card can be used for this test.

The expected turnaround time is approximately 3 to 4 weeks. Please confirm the current turnaround time with the laboratory.

Yes, a genetic counseling session is highly recommended to help interpret the test results and discuss their implications for you and your family.

Insurance coverage varies. Please check with your insurance provider regarding coverage for genetic testing.

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp